The Relationship Between Sleep and Alzheimer’s Disease Progression
About the Research Project
Program
Award Type
Standard
Award Amount
$300,000
Active Dates
July 01, 2021 - June 30, 2024
Grant ID
A2021041S
Goals
We will study how Alzheimer’s disease affects sleep quality, and whether improving sleep quality using cortical stimulation can mitigate disease progression in an Alzheimer’s disease mouse model. In Aim 1, we will investigate how sleep quality differs between normal and Alzheimer’s disease model mice. We will visualize the neural circuit activity during high- and low-quality sleep using advanced microscopy. In Aim 2, we will modify the sleep quality using a technique that has been used in the field of learning and memory. We will optogenetically stimulate a small portion of the cerebral cortex at the frequency of slow wave sleep, and examine how it influences amyloid beta (Aß) accumulation, which is tightly linked with Alzheimer’s disease progression.
Summary
Alzheimer’s disease (AD) is the most prevalent type of dementia, for which there is no effective treatment. Sleep disturbance is both an early symptom of AD in the prodromal phase, and one of the factors that exacerbates AD. Thus, detecting sleep disturbance and correcting it at an early phase of AD could be an effective treatment approach for delaying or even preventing the onset of cognitive decline. Toward this goal, it is necessary to obtain a mechanistic understanding of the relationship between sleep and AD progression. In this proposal, we will approach this question by studying the interactions between these two factors at the level of cortical circuits in an AD mouse model.
Unique and Innovative
First, our approach of using longitudinal in vivo two-photon imaging of the neural circuits and Aß plaque formation provides a unique opportunity to identify the precise relationship between sleep disturbance and Aß deposition at the level of cortical circuits. Second, our optogenetic stimulation approach will clarify how to manipulate specific types of cells in the cortex to restore sleep quality. Together, these novel approaches will link the effects of brain modulation during sleep to specific components of the neural circuits.
Foreseeable Benefits
Successful completion of the project will lead to improved strategies to restore sleep quality during the early phases of Alzheimer’s disease. Potentially, these approaches could also prevent or delay the progression of cognitive decline, providing a much-needed treatment option for Alzheimer’s disease patients.
Grants
Related Grants
Alzheimer's Disease Research
Identifying Women-Specific and Men-Specific Risk Factors for Alzheimer’s Disease
Active Dates
July 01, 2022 - June 30, 2024
Principal Investigator
Gael Chetelat, PhD
Identifying Women-Specific and Men-Specific Risk Factors for Alzheimer’s Disease
Active Dates
July 01, 2022 - June 30, 2024
Principal Investigator
Gael Chetelat, PhD
Alzheimer's Disease Research
Mitochondrial Prodrug to Treat Repeated Mild Traumatic Brain Injury
Active Dates
September 08, 2021 - December 31, 2023
Principal Investigator
Patrick Sullivan, PhD
Mitochondrial Prodrug to Treat Repeated Mild Traumatic Brain Injury
Active Dates
September 08, 2021 - December 31, 2023
Principal Investigator
Patrick Sullivan, PhD
Alzheimer's Disease Research
Advancing the Promising Cerebroprotectant AST-004 to Human Clinical Trials
Active Dates
July 02, 2021 - June 30, 2024
Principal Investigator
William Korinek, PhD
Advancing the Promising Cerebroprotectant AST-004 to Human Clinical Trials
Active Dates
July 02, 2021 - June 30, 2024
Principal Investigator
William Korinek, PhD